NPI: 1912329434 · LINTHICUM, MD 21090 · Durable Medical Equipment & Medical Supplies · NPI assigned 01/17/2014
Authorized official SPRINKEL, GEORGE controls 15+ related entities in our dataset. Read more
| Authorized Official | SPRINKEL, GEORGE (CFO) |
| Parent Organization | UNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION |
| NPI Enumeration Date | 01/17/2014 |
Other providers sharing the same authorized official: SPRINKEL, GEORGE
| Provider | City | State | Total Paid |
|---|---|---|---|
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $18.03M |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $16.54M |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $10.19M |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $9.24M |
| MARYLAND GENERAL HOSPITAL, INC. | BALTIMORE | MD | $7.12M |
| MARYLAND GENERAL HOSPITAL INC | BALTIMORE | MD | $3.33M |
| UNIVERSITY OF MARYLAND MIDTOWN HEALTH INC | BALTIMORE | MD | $3.15M |
| MARYLAND GENERAL CLINICAL PRACTICE GROUP, INC. | BALTIMORE | MD | $1.38M |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $1.07M |
| MARYLAND GENERAL HOSPITAL, INC. | BALTIMORE | MD | $524K |
| MARYLAND GENERAL CLINICAL PRACTICE GROUP, INC. | BALTIMORE | MD | $395K |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $210K |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $193K |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $59K |
| UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC | BALTIMORE | MD | $0.00 |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,089 | $430.13 |
| 2019 | 5,935 | $47K |
| 2020 | 5,415 | $111K |
| 2021 | 8,494 | $146K |
| 2022 | 12,484 | $209K |
| 2023 | 9,545 | $198K |
| 2024 | 4,937 | $92K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 17,144 | 8,842 | $453K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 10,478 | 9,414 | $341K |
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 3,018 | 1,609 | $4K |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 10,570 | 6,525 | $4K |
| J7518 | Mycophenolic acid, oral, 180 mg | 7,571 | 6,677 | $3K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,597 | 3,145 | $109.56 |
| J7517 | Mycophenolate mofetil, oral, 250 mg | 521 | 453 | $0.00 |